Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Community-based Phase III, Cluster Randomized Trial of Point-of-care CD4 Testing and Enhanced Screening and Prophylaxis in Advanced HIV Disease

NCT05085171 is registered in ClinicalTrials.gov with Makerere University as lead sponsor.

NCT NCT05085171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05085171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Community-based Phase III, Cluster Randomized Trial of Point-of-care CD4 Testing and Enhanced Screening and Prophylaxis in Advanced HIV Disease
Lead sponsor
Makerere University
Phase
Phase 3
Overall status
Recruiting
Start date
May 4, 2022
Completion date
September 1, 2027
Enrollment
2,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the study will focus on assessing the survival benefit on an enhanced package of care for patients with advanced hiv disease